Institution statistics

BAYER SCHERING PHARMA AG - Germany 

This institution has been merged with: BAYER.

Ranking results:

Past rankings:
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2007 0 10.728.701 325.112 1
2004 0 9.100.000 275.758 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ACROSS BARRIERS1
AVANTEA1
BIODETECTION SYSTEMS BV1
BOURGAS "PROF AS ZLATAROV" UNIVERSITY LABORATORY OF MATHEMATICAL CHEMISTRY1
BRACCO IMAGING1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORZIO PER L'INCREMENTO ZOOTECNICO1
COPENHAGEN UNIVERSITY1
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA RECHERCHE ET DEVELOPPEMENT1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ENTE PER LE NUOVE TECNOLOGIE L'ENERGIA E L'AMBIENTE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
FEDERAL INSTITUTE FOR RISK ASSESSMENT1
GUERBET1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
IN VITRO TESTING INDUSTRIAL PLATFORM1
INFUTURIA GROUP1
INTEGRATED DNA TECHNOLOGIES BVBA1
ISTITUTO SPERIMENTALE ITALIANO "LAZZARO SPALLANZANI"1
ISTITUTO SUPERIORE DELLA SANITA1
JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT A DIVISION OF JANSSEN PHARMACEUTICA N V1
JOINT RESEARCH CENTER1
LIVERPOOL JOHN MOORES UNIVERSITY1
MAGFORCE NANOTECHNOLOGIES1
MERCK SERONO1
MERCKSERONO1
MOLECULAR PROFILES1
N V ORGANON1
NETHERLANDS ORGANIZATION FOR APPLIED SCIENTIFIC RESEARCH1
PCI BIOTECH AS1
PFIZER PGRD1
PHILIPPSUNIVERSITAET MARBURG1
PHILIPS ELECTRONICS NEDERLAND B V1
PHILIPS TECHNOLOGIE GMBH FORSCHUNGSLABORATORIEN1
PROTEOSYS1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
RIJKSUNIVERSITEIT GRONINGEN1
STEINBEIS TECHNOLOGYTRANSFER CENTER FOR INVITRO PHARMACOLOGY AND TOXICOLOGY1
STICHTING BIOMADE TECHNOLOGY1
STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE FOM1
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER1
TECHNISCHE UNIVERSITEIT EINDHOVEN1
UNIVERSIDAD NACIONAL DE EDUCACION A DISTANCIA1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET DES SAARLANDES1
UNIVERSITAET FUER BODENKULTUR WIEN1
UNIVERSITAETSKLINIKUM FREIBURG FUER DIE MEDIZINISCHE FAKULTAET DER ALBERT LUDWIGS UNIVERSITAET1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITEIT GENT1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF KONSTANZ1
UNIVERSITY OF KUOPIO1
UNIWERSYTET LODZKI1
UPPSALA UNIVERSITET1
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK NV1
VRIJE UNIVERSITEIT BRUSSEL1
WEIZMANN INSTITUTE OF SCIENCE1
Constancy:

Total number of partners:63

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 63

Frequent / Rare Partner Ratio: 0

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES2
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2007-01-01Targeted delivery of nanomedicine MEDITRANSparticipant10.728.70133
2004-07-01Development of a novel approach in hazard and risk assessment or reproductive toxicity by a combination and application of in vitro, tissue and sensor technologies REPROTECTparticipant9.100.00033
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum